BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 12455038)

  • 1. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
    Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):226-32. PubMed ID: 12455037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
    Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
    Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
    Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
    Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
    BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C
    Br J Cancer; 2003 Aug; 89(3):502-4. PubMed ID: 12888820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
    Gao SJ; Kingsley L; Hoover DR; Spira TJ; Rinaldo CR; Saah A; Phair J; Detels R; Parry P; Chang Y; Moore PS
    N Engl J Med; 1996 Jul; 335(4):233-41. PubMed ID: 8657239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.
    Wakeham K; Johnston WT; Nalwoga A; Webb EL; Mayanja BN; Miley W; Elliott AM; Whitby D; Newton R
    Int J Cancer; 2015 Jun; 136(12):2822-30. PubMed ID: 25395177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
    Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Kaposi's sarcoma-associated herpesvirus among men who have sex with men in Japan.
    Katano H; Yokomaku Y; Fukumoto H; Kanno T; Nakayama T; Shingae A; Sugiura W; Ichikawa S; Yasuoka A
    J Med Virol; 2013 Jun; 85(6):1046-52. PubMed ID: 23588730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients.
    Mancuso R; Brambilla L; Agostini S; Biffi R; Hernis A; Guerini FR; Agliardi C; Tourlaki A; Bellinvia M; Clerici M
    J Gen Virol; 2011 Apr; 92(Pt 4):744-51. PubMed ID: 21216985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma.
    Guttman-Yassky E; Kra-Oz Z; Dubnov J; Friedman-Birnbaum R; Segal I; Zaltzman N; Roth T; Schwartz F; Linn S; Rozenman D; David M; Silbermann M; Barchana M; Bergman R; Sarid R
    Arch Dermatol; 2005 Nov; 141(11):1429-34. PubMed ID: 16301390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against human herpesvirus 8 in black South African patients with cancer.
    Sitas F; Carrara H; Beral V; Newton R; Reeves G; Bull D; Jentsch U; Pacella-Norman R; Bourboulia D; Whitby D; Boshoff C; Weiss R
    N Engl J Med; 1999 Jun; 340(24):1863-71. PubMed ID: 10369849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel.
    Iscovich J; Fischbein A; Fisher-Fischbein J; Freedman LS; Eng SM; Boffetta P; Vudovich A; Glasman C; Goldschmidt R; Livingston M; Heger-Maslansky B; Brennan P; Moore PS
    Anticancer Res; 2000; 20(3B):2119-22. PubMed ID: 10928163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.
    Miller G; Rigsby MO; Heston L; Grogan E; Sun R; Metroka C; Levy JA; Gao SJ; Chang Y; Moore P
    N Engl J Med; 1996 May; 334(20):1292-7. PubMed ID: 8609946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma in South Africa.
    Sitas F; Newton R
    J Natl Cancer Inst Monogr; 2001; (28):1-4. PubMed ID: 11158199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems.
    Preiser W; Szép NI; Lang D; Doerr HW; Rabenau HF
    Med Microbiol Immunol; 2001 Dec; 190(3):121-7. PubMed ID: 11827200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Kaposi's sarcoma associated herpesvirus among men attending sexually transmitted infections clinics in Anhui, China.
    Wang J; Liu S; Cao Y; Yang L; Chen Y; Minhas V; Wood C; Zhang T
    J Med Virol; 2016 Feb; 88(2):304-11. PubMed ID: 26147809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.